Tibet Weixinkang Medicine Co., Ltd. (603676.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
689
First IPO Date
July 21, 2017
| Name | Title | Pay | Year Born |
| Yanxia Zheng | Financial Director | 0 | 1979 |
| Liqun Yao | Accounting Supervisor | 0 | N/A |
| Feng Liu | Vice Chairman & Deputy GM | 0 | 1973 |
| Haibo Yu | Board Secretary | 0 | 1979 |
| Yong Zhang | Chairman of the Board & GM | 0 | 1972 |
| Xiaobing Zhou | Deputy General Manager | 0 | 1976 |
| Shigong Chen | Deputy GM & Director | 0 | 1973 |
| Zizhong Weng | Deputy General Manager | 0 | 1964 |
Tibet Weixinkang Medicine Co., Ltd., a pharmaceutical enterprise headquartered in Lhasa, China, is dedicated to the entire lifecycle of medicinal products within the country, encompassing their research and development, manufacturing, and sales. The company's diverse range of offerings includes specialized vitamins for parenteral nutrition, electrolyte solutions, intravenous iron preparations, antibiotic medications, and therapies designed for digestive system and liver conditions. Among its specific injectable products are multivitamins, potassium magnesium aspartate, iron sucrose, and potassium aspartate. Established in 2006, the firm operated under the name Weixinkang Medicine Youxian Gongsi until its rebranding to Tibet Weixinkang Medicine Co., Ltd. occurred in 2015.